2m 2m 2m 2m 2m 2m 2m
ALLOGENE THERAP (ALLO)
NASDAQ
$1.78-$0.004 (-0.22%)
Price as of Sep 11, 2026 7:53 PM EDT- $615.0MMarket Cap
- 57.52%1-Year Change
- BiotechnologyIndustry
ALLOGENE THERAP (ALLO)
$1.78-$0.004 (-0.22%)
ALLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.78 | ||
Change | +$0.02 (+1.14%) | ||
Open | $1.80 | ||
High | $1.80 | ||
Low | $1.75 | ||
Previous Close | $1.76 | ||
Volume | 3,894,338 | ||
30-Day Average Volume | 5,074,975 | ||
1-Week Change | -9.64% | ||
1-Month Change | -16.04% | ||
1-Year Change | 57.52% | ||
3-Year Change | -56.69% | ||
5-Year Change | -92.81% | ||
Fundamentals | |||
Shares Outstanding | 345.5M | ||
Total Assets | $550.1M | ||
Market Cap | $615.0M | ||
Enterprise Value | $576.3M | ||
Period: QTR TTM FY | |||
Revenue | $4.6M | ||
Net Income | -$42.7M | ||
Free Cash Flow | -$32.1M | ||
EBIT | -$42.7M | ||
EBITDA | -$40.0M | ||
Net Working Capital | $308.3M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 124 | ||
P/B | 1 | ||
P/E | -14 | ||
PEG | -0 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue